Clinical Trials in San Francisco

Showing 8461-8480 of 12,991 trials

DDI Effectiveness and Clinical Awareness

NCT03581994

The DECART study will determine if primary care physicians, including internists and family physicians, are able to identify and address drug-drug interactions among simulated patients and whether those physicians, when given access to Aegis Drug-Drug Interaction test results, improve patient management, take steps to reduce DDI risk, and optimize unnecessary resource utilization.

Drug-Drug Interactions

Qure Healthcare, LLC330 participantsStarted May 2018

San Francisco, California, United States

COMPLETED< 1 mile

DF4 Connector System Post-Approval Study

NCT01638897

The purpose of this study is to evaluate long-term performance of the DF4 Connector System. This evaluation is based on the number of DF4 lead-related complications occurring during the study compared to the number of leads enrolled in the study. The DF4 systems will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the DF4 Connector Systems. This study is conducted within Medtronic's post-market surveillance platform.

Ventricular TachycardiaVentricular FibrillationSudden Cardiac Death+1 more

Medtronic1,778 participantsStarted Jan 2012

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Gilbert, Arizona, United States +75 more locations

DDI Effectiveness and Clinical Awareness

DF4 Connector System Post-Approval Study

Find Trials by Condition in San Francisco

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

Safety Study of ExAblate for the Treatment of Uterine Fibroids

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Whole-Body Cooling for Birth Asphyxia in Term Infants

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)

UltraShape Power for Abdominal Fat and Circumference Reduction

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

52-104 Week Off-therapy Second Extension to Study CSPP100A2365